Guardant Health (MEX:GH) Construction In Progress: MXN651 Mil (As of Mar. 2026)


MEX:GH Guardant Health Inc MEX:GH
13 GF Score
Price MXN2,590.00
GF Value MXN1,048.04
! 4 Warning Signs
View Full Analysis

What is Guardant Health Construction In Progress?

Guardant Health MEX:GH +24.52% 13 Construction In Progress is MXN651 Mil as of Mar. 2026. GuruFocus rates MEX:GH with a GF Score™ of 13/100 and a GF Value™ of MXN1,048.04. The stock has 4 warning signs investors should review.

Guardant Health's quarterly construction in progress increased from Sep. 2025 (MXN392 Mil) to Dec. 2025 (MXN743 Mil) but then declined from Dec. 2025 (MXN743 Mil) to Mar. 2026 (MXN651 Mil).

Guardant Health's annual construction in progress increased from Dec. 2023 (MXN127 Mil) to Dec. 2024 (MXN587 Mil) and increased from Dec. 2024 (MXN587 Mil) to Dec. 2025 (MXN743 Mil).

Guardant Health Construction In Progress Historical Data

* Premium members only.

The historical data trend for Guardant Health's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardant Health Construction In Progress Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,146.18 401.58 127.44 586.80 742.77

Guardant Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 455.48 393.00 392.33 742.77 650.51
MEX:GH
13GF Score
Guardant Health Inc MEX:GH
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardant Health Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of MXN651 Mil mean?
Guardant Health (MEX:GH) has a Construction In Progress of MXN651 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Guardant Health and its competitors.
Is Guardant Health's Construction In Progress too high?
Guardant Health's current Construction In Progress is MXN651 Mil. Overall, Guardant Health has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Construction In Progress compare to LH and DGX?
Guardant Health's Construction In Progress of MXN651 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Diagnostics & Research company?
A good Construction In Progress depends on the Medical Diagnostics & Research industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Guardant Health and its competitors. Guardant Health's current Construction In Progress is MXN651 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Guardant Health (MEX:GH) has a current Construction In Progress of MXN651 Mil. The stock's GF Value™ is MXN1,048.04, compared to a current price of MXN2,590.00 — trading 147.1% above its estimated fair value. The current Construction In Progress is MXN651 Mil. Guardant Health's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Guardant Health (MEX:GH), the current Construction In Progress is MXN651 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guardant Health (MEX:GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of MXN2,590.00 is trading 147.1% above its estimated GF Value™ of MXN1,048.04.

Key valuation signals for MEX:GH:

  • Construction In Progress: MXN651 Mil
  • GF Value™: MXN1,048.04 vs. price of MXN2,590.00 (147.1% above fair value)
  • GF Score™: 13/100 with 4 warning signs

No single metric tells the full story. See the MEX:GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guardant Health Business Description

Other Exchanges GH:USA1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
13GF Score

Get the complete analysis for MEX:GH

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,590.00
Price
MXN1,048.04
GF Value